{"id":192647,"date":"2026-08-10T11:16:32","date_gmt":"2026-08-10T05:46:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=192647"},"modified":"2026-08-10T11:16:32","modified_gmt":"2026-08-10T05:46:32","slug":"ngl-fine-chem-ltd-share-price-near-52-week-high-2026-08-10","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ngl-fine-chem-ltd-share-price-near-52-week-high-2026-08-10\/","title":{"rendered":"NGL Fine-Chem Ltd. (NGLFINE) Share Price Within 2% of 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/nglfine\/ngl-fine-chem-ltd-share-price-today\">NGL Fine-Chem Ltd.<\/a> trades at Rs 3,487.8, within 2% of its 52-week high, with a market capitalisation of Rs 2,118.6 crore.<\/p>\n<p style=\"margin-top:0!important;\">NGL Fine-Chem Ltd. Share Price is at Rs 3,487.8 at the time of the Univest screener qualification, placing the stock within 2% of its 52-week high and valuing the company at a market capitalisation of Rs 2,118.6 crore. For investors tracking NGL Fine-Chem Ltd. Share Price Today, that proximity to a one-year peak is notable because it signals sustained market attention even without a verified company-specific trigger in the supplied data.<\/p>\n<p>The event-time last traded price, or LTP, was Rs 3,487.8 at 10:30:37 AM IST on 10 August 2026. The supplied data confirms the price event but does not establish a company-specific catalyst. That makes the current setup more relevant as a market-structure and valuation story: the stock is trading close to its yearly high while also carrying a P\/E of 44.02, a P\/B of 6.43, ROE of 27.9 and ROCE of 33.91. Univest data therefore points investors toward a broader stock analysis question around whether operating quality, relative valuation and sector positioning are supporting the attention around NGL Fine-Chem Ltd. Share Price.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"NGL_Fine-Chem_Ltd_Share_Price_Today_Within_2_of_52-Week_High\"><\/span><strong>NGL Fine-Chem Ltd. Share Price Today: Within 2% of 52-Week High<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>LTP at 2% Qualification<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,487.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,118.6 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>52-Week High Position<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Trading within 2% of its 52-week high<\/td>\n<\/tr>\n<\/table>\n<p>NGL Fine-Chem Ltd. (NGLFINE) traded at Rs 3,487.8. Reported volume was 191.<\/p>\n<p>NGL Fine-Chem Ltd. Share Price Today stands at Rs 3,487.8 based on the event-qualified LTP captured by the Univest screener at 10:30:37 AM IST. The same screener identifies the stock as trading within 2% of its 52-week high, which is often enough to bring a company onto more investor watchlists even before any breakout or fresh record is confirmed. In practical terms, a stock trading this close to its yearly high is usually being judged not just on a single session move, but on the persistence of its broader re-rating.<\/p>\n<p>For readers following NGL Fine-Chem Ltd. Stock News, the key point is that the event is factual and price-based. The supplied data confirms proximity to the 52-week high and confirms the current market value of Rs 2,118.6 crore, but it does not tie the move to a fresh corporate update. That keeps the focus on how the market is valuing the business at this stage of the cycle.<\/p>\n<p>When NGL Fine-Chem Ltd. Share Price trades near a one-year high, investors often start comparing current valuation and profitability against the wider Healthcare and Pharmaceuticals &#038; Drugs space. A higher-quality balance between earnings power and valuation can justify attention, while a richer multiple can also raise the bar for future execution. That is why the next step in analysing NGL Fine-Chem Ltd. Share Price is to move from the event itself to the company\u2019s fundamentals and benchmark positioning.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"NGL_Fine-Chem_Ltd_NGLFINE_Fundamental_Analysis\"><\/span><strong>NGL Fine-Chem Ltd. (NGLFINE) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,118.6 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.43x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">33.91%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 77.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 532.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.05%<\/td>\n<\/tr>\n<\/table>\n<p>NGL Fine-Chem Ltd. was valued at a P\/E ratio of 44.02x, a P\/B ratio of 6.43x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 27.9% and ROCE of 33.91%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<p>Per-share and shareholder-return metrics included EPS of Rs 77.9, book value per share of Rs 532.92, dividend yield of 0.05%. Dividend yield is a current or historical ratio and does not guarantee future distributions.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.11x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">60.11x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,417.8x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.43x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.82x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">33.91%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.62%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,118.6 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 142.3 crore<\/td>\n<\/tr>\n<\/table>\n<p>NGL Fine-Chem Ltd. (NGLFINE) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>NGL Fine-Chem Ltd. (NGLFINE) has a P\/E ratio of 44.02x, which is above the benchmark median of 18.11x, a difference of +143.07%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>NGL Fine-Chem Ltd. (NGLFINE) has a ROE of 27.9%, which is above the benchmark median of 9.89%, a difference of +182.1%. NGL Fine-Chem Ltd. (NGLFINE) has a ROCE of 33.91%, which is above the benchmark median of 12.62%, a difference of +168.7%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/venusrem\/venus-remedies-ltd-share-price-today\"><strong>Venus Remedies Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">VENUSREM-BE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,068.61<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.89<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hesterbio\/hester-biosciences-ltd-share-price-today\"><strong>Hester Biosciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HESTERBIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,057.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.12<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\"><strong>Fredun Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">FREDUN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,057.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sakar\/sakar-healthcare-ltd-share-price-today\"><strong>Sakar Healthcare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAKAR<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,057.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">56.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indoco\/indoco-remedies-ltd-share-price-today\"><strong>Indoco Remedies Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INDOCO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,045.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">363.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.67<\/td>\n<\/tr>\n<\/table>\n<p>NGL Fine-Chem Ltd. (NGLFINE) has a P\/E ratio of 44.02x compared with the displayed peer median of 46.96x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.9% compares with a peer median of 11.88% across the companies shown in the table. ROCE stood at 33.91% versus the displayed peer median of 13.16%, providing a capital-efficiency comparison. NGL Fine-Chem Ltd. (NGLFINE) has a market capitalisation of Rs 2,118.6 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_NGL_Fine-Chem_Ltd\"><\/span><strong>Why Investors Are Watching NGL Fine-Chem Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>NGL Fine-Chem Ltd. Share Price is at Rs 3,487.8 and the stock is trading within 2% of its 52-week high, which naturally increases market visibility.<\/li>\n<li>The company carries a market capitalisation of Rs 2,118.6 crore, putting it above the industry median size of Rs 142.3 crore and above the average of Rs 477.72 crore.<\/li>\n<li>Valuation is elevated versus the same-industry median, with P\/E at 44.02 against 18.11 and P\/B at 6.43 against 1.82.<\/li>\n<li>Profitability is stronger than industry benchmark levels, with ROE at 27.9 versus 9.89 and ROCE at 33.91 versus 12.62.<\/li>\n<li>Peer comparison shows NGL Fine-Chem Ltd. Share Price sits in a premium zone, but with stronger ROE and ROCE than several similarly sized listed peers.<\/li>\n<li>Univest screening has flagged a clear market event, making NGL Fine-Chem Ltd. Stock News relevant for investors who track yearly high setups alongside fundamentals.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_NGL_Fine-Chem_Ltd\"><\/span><strong>About NGL Fine-Chem Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>NGL Fine-Chem Ltd. is a listed Indian company tracked under the symbol NGLFINE. Based on the supplied classification, it operates in the Healthcare sector and is part of the Pharmaceuticals &#038; Drugs industry. For investors following NGL Fine-Chem Ltd. Share Price, that industry placement matters because it frames the company against other pharmaceutical and drug businesses on valuation, profitability and market-cap metrics.<\/p>\n<p>The available data set positions the company as a mid-sized listed name in its industry, with a market capitalisation of Rs 2,118.6 crore. It also shows that the market currently attaches relatively high profitability ratios to the business, with ROE of 27.9 and ROCE of 33.91. Those figures, combined with a P\/E of 44.02 and P\/B of 6.43, indicate that the market is evaluating NGL Fine-Chem Ltd. as a quality player within its industry set. On Univest, investors typically view NGL Fine-Chem Ltd. Share Price in this wider context of sector classification, peer ranking and fundamentals rather than as an isolated price move.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_NGL_Fine-Chem_Ltd_Share_Price_on_Univest\"><\/span><strong>Track NGL Fine-Chem Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/nglfine\/ngl-fine-chem-ltd-share-price-today\">NGL Fine-Chem Ltd. (NGLFINE) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors tracking NGL Fine-Chem Ltd. Share Price can use Univest to follow live share price updates, 52-week levels, valuation ratios, profitability metrics and broader market context in one place. That makes it easier to connect a screener event such as trading within 2% of a 52-week high with deeper stock analysis.<\/p>\n<p>On Univest, users can monitor NGL Fine-Chem Ltd. Share Price Today alongside indicators such as market capitalisation, P\/E, P\/B, ROE, ROCE, EPS, book value and dividend yield. They can also compare the company with Healthcare and Pharmaceuticals &#038; Drugs peers, track shareholding data when available and review market insights built around verified figures. For investors following NGL Fine-Chem Ltd. Stock News, that combination helps separate factual price events from interpretation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_NGL_Fine-Chem_Ltd_Share_Price_today\"><\/span><strong>What is NGL Fine-Chem Ltd. Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> NGL Fine-Chem Ltd. Share Price was Rs 3,487.8 at the event-qualified LTP captured on 10 August 2026 at 10:30:37 AM IST. The stock was also identified by the Univest screener as trading within 2% of its 52-week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_NGL_Fine-Chem_Ltd_Share_Price_near_its_52-week_high\"><\/span><strong>Why is NGL Fine-Chem Ltd. Share Price near its 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that NGL Fine-Chem Ltd. Share Price is within 2% of its 52-week high at an LTP of Rs 3,487.8. It confirms the price event, but it does not establish any specific company-side catalyst behind the move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_NGL_Fine-Chem_Ltd_expensive_on_valuation_metrics\"><\/span><strong>Is NGL Fine-Chem Ltd. expensive on valuation metrics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> NGL Fine-Chem Ltd. Share Price reflects a P\/E of 44.02 and P\/B of 6.43. Both are above the same-industry median levels of 18.11 and 1.82, showing that the stock is trading at a premium to benchmark medians.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_strong_are_NGL_Fine-Chem_Ltds_profitability_ratios\"><\/span><strong>How strong are NGL Fine-Chem Ltd.&#39;s profitability ratios?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Profitability looks strong in the supplied data. NGL Fine-Chem reports ROE of 27.9 and ROCE of 33.91, both comfortably above the same-industry medians of 9.89 and 12.62, which strengthens the context behind its premium valuation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_large_is_NGL_Fine-Chem_Ltd_within_its_industry\"><\/span><strong>How large is NGL Fine-Chem Ltd. within its industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> NGL Fine-Chem Ltd. has a market capitalisation of Rs 2,118.6 crore. That is above the same-industry median market cap of Rs 142.3 crore and above the average of Rs 477.72 crore across the 139-company benchmark universe.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_and_industry_does_NGL_Fine-Chem_Ltd_belong_to\"><\/span><strong>Which sector and industry does NGL Fine-Chem Ltd. belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> NGL Fine-Chem Ltd. is classified under the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. Univest sector comparison uses a same-industry benchmark of 139 companies, with a broader sector set covering 201 companies.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_NGL_Fine-Chem_Ltd_compare_with_peers\"><\/span><strong>How does NGL Fine-Chem Ltd. compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> NGL Fine-Chem Ltd. sits near peers such as Venus Remedies, Hester Biosciences, Fredun Pharmaceuticals, Sakar Healthcare and Indoco Remedies on market cap. Its ROE of 27.9 and ROCE of 33.91 are stronger than each of those five peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_EPS_book_value_and_dividend_yield_add_context_to_NGL_Fine-Chem_Ltd_Share_Price\"><\/span><strong>Do EPS, book value and dividend yield add context to NGL Fine-Chem Ltd. Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. The supplied figures show EPS of 77.9, book value per share of Rs 532.92 and dividend yield of 0.05. Together, they add earnings, balance-sheet and payout context to NGL Fine-Chem Ltd. Share Price analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_investors_track_NGL_Fine-Chem_Ltd_Share_Price_on_Univest\"><\/span><strong>Where can investors track NGL Fine-Chem Ltd. Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can track NGL Fine-Chem Ltd. Share Price on Univest for live price updates, 52-week levels, valuation ratios, profitability data, peer comparison and market insights. That helps place near-52-week-high moves in a broader analytical context.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NGL Fine-Chem Ltd. Share Price trades within 2% of its 52-week high at Rs 3,487.8. Market cap stands at Rs 2,118.6 crore.<\/p>\n","protected":false},"author":29,"featured_media":192646,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-192647","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["192646"],"rank_math_title":["NGL Fine-Chem Ltd. Share Price Within 2% of 52-Week High"],"rank_math_description":["NGL Fine-Chem Ltd. Share Price is near its 52-week high. Explore price action, valuation metrics, profitability and industry benchmark context."],"rank_math_focus_keyword":["NGL Fine-Chem Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/NGL_Fine_Chem_Ltd_NGLFINE_Share_Price_Within_2_of_52_Week_High_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/192647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=192647"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/192647\/revisions"}],"predecessor-version":[{"id":192649,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/192647\/revisions\/192649"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/192646"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=192647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=192647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=192647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}